![Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-017-01257-1/MediaObjects/41467_2017_1257_Fig1_HTML.jpg)
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications
![On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-64518-y/MediaObjects/41598_2020_64518_Fig1_HTML.png)
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
![CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001 CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001](https://pubs.rsc.org/image/chapter/bk9781788010771/bk9781788010771-00001/bk9781788010771-00001-u1_hi-res.gif)
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
![CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001 CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001](https://pubs.rsc.org/image/chapter/bk9781788010771/bk9781788010771-00001/bk9781788010771-00001-f4_hi-res.gif)
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
![Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin | Scientific Reports Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-32601-0/MediaObjects/41598_2018_32601_Fig1_HTML.png)
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin | Scientific Reports
![Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL](https://xpic.x-mol.com/20190904%2F10.1021_acs.analchem.9b02192.jpg)
Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL
![Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-38745-x/MediaObjects/41598_2019_38745_Fig1_HTML.png)
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports
![Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/445531/445531_Thumb_400.jpg)
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
![Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International](https://bioprocessintl.com/wp-content/uploads/2018/10/Figure1_1.jpg)
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
![Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H](https://pubs.rsc.org/image/article/2019/CS/c8cs00676h/c8cs00676h-f1_hi-res.gif)
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
![Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41551-019-0470-8/MediaObjects/41551_2019_470_Fig1_HTML.png)